Nav: Home

CU School of Medicine's Kenneth Tyler article in New England Journal of Medicine

August 09, 2018

AURORA, Colo. (Aug. 9, 2018) - Kenneth Tyler, MD, the Louise Baum Endowed Chair in Neurology at the University of Colorado School of Medicine, is author of a review article about acute viral encephalitis in the current issue of The New England Journal of Medicine.

Review articles are a regular feature in the prestigious medical journal and are written by experts in their fields who offer an overview of the current knowledge about a specific health condition. Such articles discuss a condition's epidemiology, clinical profiles, and diagnostic strategies.

Tyler, who holds appointments in the CU School of Medicine's departments of neurology, medicine, and immunology and microbiology, is a leading researcher and clinician contributing to a better understanding of acute viral encephalitis and improved care for patients infected with the virus. The School of Medicine is home to an internationally recognized Neuro-Infectious Diseases Group, a multidisciplinary collaborative of faculty whose goal is to better understand infectious diseases that affect the nervous system. The group is involved in basic science, clinical, and epidemiologic research projects.

"Viral encephalitis is a major cause of illness and death and imposes a heavy economic burden," Tyler writes in the article, which was published today. "Diagnostic strategies and technologies are being developed to allow identification of an expanding list of pathogens and to differentiate viral encephalitis from its mimics....New therapies to prevent infection and inhibit viral replication are needed."

Each year in the United States, about seven patients are hospitalized for encephalitis per 100,000 population and the cause is unknown in about half of these cases. The estimated median hospitalization charge for a patient with viral encephalitis is $89,600 for West Nile virus encephalitis and $58,000 for HSV [herpes simplex virus] encephalitis. Total annual cost nationally is estimated at $350 million to $540 million, not including the cost of care after discharge, costs for family caregivers, and lost earnings.

Earlier this week, the Colorado Department of Public Health and Environment issued a news release announcing that the first two human cases of West Nile virus in the state in 2018 have been reported in Weld and Delta counties. West Nile virus is most commonly spread to humans by mosquito bites. While most people infected with the virus do not have symptoms, a small percentage (less than 1 percent) can develop neuro-invasive disease, such as encephalitis.
-end-
About the University of Colorado School of Medicine

Faculty at the University of Colorado School of Medicine work to advance science and improve care. These faculty members include physicians, educators and scientists at UCHealth's University of Colorado Hospital, Children's Hospital Colorado, Denver Health, National Jewish Health, and the Denver Veterans Affairs Medical Center. The school is located on the Anschutz Medical Campus, one of four campuses in the University of Colorado system. To learn more about the medical school's care, education, research and community engagement, visit its web site.

University of Colorado Anschutz Medical Campus

Related West Nile Virus Articles:

West Nile virus triggers brain inflammation by inhibiting protein degradation
West Nile virus (WNV) inhibits autophagy -- an essential system that digests or removes cellular constituents such as proteins -- to induce the aggregation of proteins in infected cells, triggering cell death and brain inflammation (encephalitis), according to Hokkaido University researchers.
WSU study shows insulin can increase mosquitoes' immunity to West Nile virus
A discovery by a Washington State University-led research team has the potential to inhibit the spread of West Nile virus as well as Zika and dengue viruses.
Critical protein that could unlock West Nile/Zika virus treatments identified
A team of Georgia State scientists has identified a protein that is critical in controlling replication of West Nile and Zika viruses -- and could be important for developing therapies to prevent and treat those viruses.
West Nile virus in the New World: Reflections on 20 years in pursuit of an elusive foe
Though eradication of West Nile virus remains beyond our capability, the body of knowledge built since its arrival in the Americas in 1999 is now powering efforts to minimize its impact and prepare for the invasion of other mosquito-borne diseases.
Light pollution may be increasing West Nile virus spillover from wild birds
House sparrows infected with West Nile virus (WNV) that live in light polluted conditions remain infectious for two days longer than those who do not, increasing the potential for a WNV outbreak by about 41%.
Mount Sinai researchers find significant delays in West Nile virus reporting
Mount Sinai researchers found significant delays in reporting human cases of West Nile virus, hampering real-time forecasting of the potentially deadly mosquito-borne disease, according to a study in the JAMA Network Open in April.
Insecticide resistance genes affect vector competence for West Nile virus
In a context of overuse of insecticides, which leads to the selection of resistant mosquitoes, it is already known that this resistance to insecticides affects interactions between mosquitoes and the pathogens they transmit.
Where will the world's next Zika, West Nile or Dengue virus come from?
Scientists from the University of California, Davis, have identified wildlife species that are the most likely to host flaviviruses such as Zika, West Nile, dengue and yellow fever.
Vanderbilt discovery could neutralize West Nile virus
Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can 'neutralize' the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States.
Researchers develop a novel RNA-based therapy to target West Nile virus
A Yale-led research team developed a new RNA therapy, delivered through the nose, to treat mice infected with West Nile Virus.
More West Nile Virus News and West Nile Virus Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.